Related Experiment Videos

Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative

Insights

LY 127935, a novel oxa beta-lactam antibiotic, shows promising cerebrospinal fluid penetration and bactericidal activity. This makes it a potential treatment for gram-negative bacillary meningitis.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Neuroscience

Background:

  • Gram-negative bacillary meningitis poses a significant therapeutic challenge.
  • Novel antibiotics with enhanced Gram-negative spectrum are needed.

Observation:

  • LY 127935, an oxa beta-lactam, was administered intravenously to seven patients.
  • Two patients had documented Gram-negative bacillary meningitis.

Findings:

  • Cerebrospinal fluid (CSF) trough levels of LY 127935 remained above 6 µg/ml.
  • Peak CSF levels ranged from 25-39 µg/ml, reaching 19-100% of serum levels.
  • CSF demonstrated bactericidal activity against Gram-negative bacteria (1:4 to 1:256).

Implications:

  • Intravenous LY 127935 exhibits excellent CSF penetration.
  • Its broad Gram-negative spectrum suggests potential efficacy in treating Gram-negative bacillary meningitis.

Related Concept Videos